Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in mice

Suraphan Panyod1,2,3, Wei-Kai Wu3,4,5,6, Chih-Ting Chang1

  • 1Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan, ROC.

PubMed

Insights

Common dietary emulsifiers like lecithin, sucrose fatty acid esters, carboxymethylcellulose (CMC), and mono- and diglycerides (MDG) disrupt gut microbiota and metabolic health, potentially leading to diseases.

Area of Science:

  • Microbiology
  • Metabolic Health
  • Toxicology

Background:

  • Dietary emulsifiers are widely used food additives.
  • Emerging research highlights the gut microbiota's role in health and disease.
  • A safety reassessment of emulsifiers considering gut microbiota interactions is needed.

Purpose of the Study:

  • To investigate the impact of common dietary emulsifiers on gut microbiota and host metabolism.
  • To evaluate the safety of lecithin, sucrose fatty acid esters, carboxymethylcellulose (CMC), and mono- and diglycerides (MDG).

Main Methods:

  • In vivo mouse models to assess hyperglycemia, hyperinsulinemia, and glucose homeostasis.
  • In vitro insulin-resistance models.
  • Analysis of gut microbiota diversity and composition.
  • Assessment of mucus-bacterial interactions and lipopolysaccharide levels.

Main Results:

  • Sucrose fatty acid esters and CMC induced hyperglycemia and hyperinsulinemia in mice.
  • Lecithin, sucrose fatty acid esters, and CMC disrupted glucose homeostasis in vitro.
  • MDG impaired lipid and glucose metabolism.
  • All tested emulsifiers altered gut microbiota diversity, causing dysbiosis.
  • MDG promoted bacterial encroachment into the mucus layer and increased inflammation markers.

Conclusions:

  • Dietary emulsifiers pose safety concerns regarding metabolic health.
  • Emulsifier-induced gut dysbiosis may contribute to the development of metabolic syndromes.
  • Specific emulsifiers like MDG may exacerbate inflammation through gut barrier disruption.